Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients
Clinical trial NCT03272477 · COMPLETED
Trial details
- NCT number
- NCT03272477
- Sponsor
- Palleos Healthcare GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2020-07-14
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.